Iohexol plasma and urinary concentrations in cirrhotic patients: A pilot study

Figure 1 For each patient studied, proportion of the iohexol administered dose detectable as a function of time in plasma and urine.

Figure 2 Bland–Altman plots for creatinine-based formula, Royal Free Hospital formula, Brochner–Mortensen formula and iohexol urinary clearance in comparison to iohexol plasma clearance.

Figure 3 Matrix correlation and scatter plots for the iohexol plasma and urinary clearance, the creatinine-based equations, RHF and Brochner–Mortensen. CL-IOX-P: Iohexol plasma clearance; CL-IOX-U: Iohexol urinary clearance.

Figure 4 Scatter plot and boxplots between the different covariables including the grade of ascites (0 = no ascites, 1 = grade I, 2 = grade II or III) and the iohexol plasma clearance, P KW = P value for the Kruskal–Wallis test.